- Full Year 2023 Molecular Partners AG Earnings Call TranscriptMar 15, 2024€3.54 (+0.57%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Half Year 2023 Molecular Partners AG Earnings Call TranscriptAug 25, 2023€5.1 (-5.56%)Earnings
- Molecular Partners AG at TD Cowen Inc Radiopharmaceutical Innovation Summit (Virtual) TranscriptJun 20, 2023
- Molecular Partners AG at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Full Year 2022 Molecular Partners AG Earnings Call TranscriptMar 10, 2023€5.8 (+7.41%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Half Year 2022 Molecular Partners AG Earnings Call TranscriptAug 26, 2022€6.2 (+5.08%)Earnings
- Full Year 2021 Molecular Partners AG Earnings Call TranscriptMar 16, 2022€17.3 (-6.49%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Molecular Partners AG Corporate Call TranscriptJan 10, 2022
- Molecular Partners AG to Host Oncology Day (Virtual) TranscriptDec 15, 2021
- Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Half Year 2021 Molecular Partners AG Earnings Call TranscriptAug 26, 2021€16.5 (+0.61%)Earnings
- Molecular Partners AG at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Full Year 2020 Molecular Partners AG Earnings Call TranscriptFeb 05, 2021Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Molecular Partners AG - Special Call TranscriptDec 17, 2020
- Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Half Year 2020 Molecular Partners AG Earnings Call TranscriptAug 26, 2020Earnings
- Molecular Partners AG - Special Call TranscriptJun 26, 2020
- Full Year 2019 Molecular Partners AG Earnings Call TranscriptFeb 06, 2020Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Molecular Partners AG - Special Call TranscriptDec 12, 2019
- Half Year 2019 Molecular Partners AG Earnings Call TranscriptAug 27, 2019Earnings
- Full Year 2018 Molecular Partners AG Earnings Call TranscriptFeb 07, 2019Earnings
Molecular Partners AG at RBC Capital Markets Global Healthcare Conference Transcript
We'll continue this afternoon sessions. I'm Alistair Campbell, senior analyst for our European healthcare team. It's my pleasure now to have a session with Molecular Partners, being represented by CEO, Patrick Amstutz, and Seth Lewis.
Questions & Answers
What I'd like to do is just maybe start, Patrick, with just an overview, given the industry has numerous binder technologies that we're all quite familiar with for pharmaceutical applications, whether that be antibodies, antibody fragments, aptamers, [aphamers]. Your program is DARPins, so maybe we can start with an overview of the DARPin technology, its key differentiating factors, and what proof of concept data you've achieved with the platform thus far.
First of all, thanks for the invitation. We're enjoying the conference here, enjoying New York, and having many good
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)